Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Diva Laboratories's book value per share for the quarter that ended in Mar. 2026 was NT$15.96.
During the past 12 months, Diva Laboratories's average Book Value Per Share Growth Rate was -2.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 0.40% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 1.20% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -3.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Diva Laboratories was 42.90% per year. The lowest was -11.10% per year. And the median was 0.95% per year.
Diva Laboratories's current price is NT$33.10. Its book value per share for the quarter that ended in Mar. 2026 was NT$15.96. Hence, today's PB Ratio of Diva Laboratories is 2.07.
During the past 13 years, the highest P/B Ratio of Diva Laboratories was 3.37. The lowest was 1.14. And the median was 1.96.
Diva Laboratories (ROCO:4153) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Diva Laboratories Book Value per Share Related Terms
Diva Laboratories Book Value per Share Historical Data
* Premium members only.
The historical data trend for Diva Laboratories's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4153 vs TMO, DHR, IDXX: Book Value per Share Comparison
For the Diagnostics & Research subindustry, Diva Laboratories's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Diva Laboratories PB Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Diva Laboratories's PB Ratio distribution charts can be found below:
* The bar in red indicates where Diva Laboratories's PB Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Book Value per Share of NT$15.96 mean?
Diva Laboratories (ROCO:4153) has a Book Value per Share of NT$15.96 as of Mar. 2026. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Diva Laboratories and its competitors.
Is Diva Laboratories' Book Value per Share too high?
Diva Laboratories' current Book Value per Share is NT$15.96. Overall, Diva Laboratories has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Diva Laboratories' Book Value per Share compare to TMO and DHR?
Diva Laboratories' Book Value per Share of NT$15.96 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Medical Diagnostics & Research company?
A good Book Value per Share depends on the Medical Diagnostics & Research industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Diva Laboratories and its competitors. Diva Laboratories's current Book Value per Share is NT$15.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diva Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Diva Laboratories (ROCO:4153) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$38.05, compared to a current price of NT$33.10 — trading 13% below its estimated fair value. The current Book Value per Share is NT$15.96. Diva Laboratories' overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For Diva Laboratories (ROCO:4153), the current Book Value per Share is NT$15.96 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Diva Laboratories (ROCO:4153) Overvalued in 2026?
Based on GuruFocus' analysis, Diva Laboratories stock appears to be undervalued.
The current stock price of NT$33.10 is trading 13% below its estimated GF Value™ of NT$38.05.
GuruFocus considers Diva Laboratories to be Modestly Undervalued.
Key valuation signals for ROCO:4153:
Book Value per Share: NT$15.96
GF Value™: NT$38.05 vs. price of NT$33.10 (13% below fair value)
No single metric tells the full story. See the ROCO:4153 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Diva Laboratories Ltd is engaged in the sale, manufacturing and development of medical equipment and computer-related devices. Its products are divided into Medical display which includes radiology, endo/surgical, touch, and embedded display; and Industrial display which includes touch display monitors. It derives revenue from sale of Medical monitors, Medical parts, Industrial monitors, Industrial parts, and Parts. Geographically it operates and derives revenue from Taiwan.
76GF Score
Get the complete analysis for ROCO:4153
Book Value per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4153 has been successfully added to your 
